Valuation : Kenvue Inc.

Market Cap 35.32B 30.37B 28.57B 26.07B 48.66B 3,349B 48.91B 339B 131B 1,712B 133B 130B 5,447B P/E 2026 *
19.3x
P/E 2027 * 16.8x
Enterprise Value 42.42B 36.47B 34.31B 31.31B 58.44B 4,022B 58.74B 407B 157B 2,056B 159B 156B 6,541B EV / Sales 2026 *
2.72x
EV / Sales 2027 * 2.62x
Free-Float
98.88%
Yield 2026 *
4.59%
Yield 2027 * 4.69%
1 day-1.87%
1 week-1.92%
Current month-2.60%
1 month-4.37%
3 months+4.79%
Current year+6.61%
1 week 18.38
Extreme 18.38
19.18
1 month 18.38
Extreme 18.38
19.56
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
20.13
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap. Importance
7/31/26 Exercice

Executive/Senior Manager

32,838 0.0017%
5/21/26 Free

Director

10,309 0.0005%
5/21/26 Free

Chairman

16,036 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-1.87%-1.92%-0.22%-13.66% 36B
-0.59%-0.43%-8.45%-4.81% 340B
+0.04%-2.40%-11.12%+3.25% 137B
-0.41%-1.36%+5.01%+20.78% 70.77B
+1.02%-0.74%-24.54%-21.23% 48.69B
-2.09%+1.69%+14.45%-33.97% 37.58B
-0.93%-4.80%-0.55%+22.81% 20.26B
+1.11%-1.24%-21.95%-37.24% 19.17B
+0.04%-3.80%+4.39%+9.63% 18.98B
+0.36%-4.42%-29.67%-15.22% 9.33B
Average -0.12%-2.07%-7.26%-6.97% 73.78B
Weighted average by Cap. +0.56%-1.22%-7.22%-3.70%

Financials

2026 *2027 *
Net sales 15.6B 13.41B 12.61B 11.51B 21.48B 1,478B 21.59B 149B 57.83B 756B 58.56B 57.28B 2,405B 15.97B 13.73B 12.92B 11.79B 22B 1,514B 22.11B 153B 59.2B 774B 59.96B 58.65B 2,462B
Net income 1.83B 1.57B 1.48B 1.35B 2.52B 173B 2.53B 17.54B 6.79B 88.67B 6.87B 6.72B 282B 2.11B 1.82B 1.71B 1.56B 2.91B 200B 2.93B 20.25B 7.83B 102B 7.93B 7.76B 326B
Net Debt 7.1B 6.1B 5.74B 5.24B 9.78B 673B 9.83B 68.02B 26.32B 344B 26.65B 26.07B 1,094B 6.52B 5.61B 5.27B 4.81B 8.98B 618B 9.03B 62.49B 24.17B 316B 24.48B 23.95B 1,005B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-09-08 US$18.39 -1.87% 16,219,998
26-09-04 US$18.74 -1.11% 26,856,871
26-09-03 US$18.95 -0.94% 18,570,436
26-09-02 US$19.13 +2.03% 19,692,893
26-09-01 US$18.75 -0.69% 21,754,679
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
18.39USD
Average target price
19.50USD
Spread / Average Target
+6.04%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!